Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 558 | 462 | 454 | 893 | 412 |
| Gross Profit | 558 | 462 | 454 | 893 | 412 |
| Operating Expenses | 20,947 | 20,670 | 17,427 | 19,500 | 16,732 |
| Operating Income | -20,389 | -20,208 | -16,973 | -18,607 | -16,320 |
| Other Income | 596 | 753 | 512 | 575 | 583 |
| Pre-tax Income | -19,793 | -19,455 | -16,461 | -18,032 | -15,737 |
| Net Income Continuous | -19,793 | -19,455 | -16,461 | -18,032 | -15,737 |
| Net Income | $-19,793 | $-19,455 | $-16,461 | $-18,032 | $-15,737 |
| EPS Basic Total Ops | -4.70 | -4.70 | -4.90 | -5.30 | -4.70 |
| EPS Basic Continuous Ops | -4.66 | -4.67 | -4.88 | -5.36 | -4.68 |
| EPS Diluted Total Ops | -4.70 | -4.70 | -4.90 | -5.30 | -4.70 |
| EPS Diluted Continuous Ops | -4.66 | -4.67 | -4.88 | -5.36 | -4.68 |
| EBITDA(a) | $-19,746 | $-19,559 | $-16,441 | $-18,175 | $-15,912 |